位置:成果数据库 > 期刊 > 期刊详情页
人血清氧化低密度脂蛋白自身抗体的提取和初步鉴定
  • ISSN号:1001-764X
  • 期刊名称:《临床检验杂志》
  • 时间:0
  • 分类:R155.55[医药卫生—营养与食品卫生学;医药卫生—公共卫生与预防医学]
  • 作者机构:[1]南京军区南京总医院全军临床检验医学研究所, 210002, [2]湖北省肿瘤医院检验科
  • 相关基金:国家自然科学基金资助项目(30471649);江苏省自然科学基金青年科技创新人才项目(BK2006529)
中文摘要:

目的提取和鉴定人血清中氧化脂蛋白(a)[ox-Lp(a)]自身抗体,建立ox-Lp(a)ELISA检测法并进行临床研究。方法采用溴化氰活化的sepharose4B交联ox-Lp(a)制备免疫吸附层析柱,从正常人血清中提取抗ox-Lp(a)自身抗体,分析其免疫反应性。分别建立以抗ox-Lp(a)的自身抗体、抗氧化LDL(ox-LDL)多克隆抗体为包被抗体,酶标抗载脂蛋白(a)[apo(a)]为检测抗体的ox-Lp(a)ELISA检测法,并对100例冠心病患者和100名健康体检人群进行分析。结果8份正常人血清中均存在抗ox-Lp(a)自身抗体,与ox-Lp(a),ox-LDL均具有良好的反应性;再经亲和层析除出抗ox-LDL自身抗体后,2份标本同ox-Lp(a)仍具有较高的反应性。同对照组相比,本组冠心病患者血浆Lp(a)水平显著升高[(279.6±162.7)mg/L比(206.3±126.4)mg/L,P〈0.01];ox-Lp(a)水平亦明显增加(P〈0.01),采用自身抗体和抗ox-LDL抗体建立的ELISA法测定结果分别为:(24.3±33.4)μg/ml比(8.4±9.3)μ/ml和(13.0±13.8)μ/ml比(7.3±9.7)μ/ml;两种ELISA法间结果高度相关(r=0.78,P〈0.01)。结论提取的人血清ox-Lp(a)自身抗体可识别apo(a)和apoB氧化位点,采用自身抗体建立的ox-Lp(a)检测法能更真实、准确地反应体内Lp(a)的氧化状态,冠心病患者ox-Lp(a)水平显著升高。

英文摘要:

Objective To isolate and identify human autoantibodies against oxidized Lp(a) [ ox-Lp (a) ] and develop new ELISA method for ox-Lp (a) by using isolated human autoantibodies as capture antibody. Methods Ox-Lp(a) autoantibodies from healthy subjects were isolated and identified by affinity chromatography. Two "sandwich" ELISA methods for plasma ox-Lp(a) were developed by using either the human autoantibodies against ox-Lp(a) or rabbit antiserum against human ox-LDL as the capture antibodies. Enzyme-labeled monoclonal anti-ape(a) was used for the quantifications. Serum ox-Lp (a) levels in 100 coronary heart disease (CHD) patients and 100 control subjects were measured with the ELISA methods. Results Ox-Lp(a) autoantibodies were isolated from all 8 studied subjects. Autoantibodies from two of the 8 sebjects showed both reactivities to ox-LDL and ox-apo(a). The Lp(a) levels in the patients with CHD were significantly different from those of control [ (279. 6 ± 162.7 ) mg/L vs (206. 3 ± 126. 4 ) mg/L, P 〈 0.0 1 ]. Plasma ox-Lp(a) levels in patients with CHD detected by two ELISAs were both significantly higher than those of control [ ELISA using human antibodies against ox-Lp(a) : (24.3 ± 33.4) μg/ml vs (8.4 ± 9. 3 ) μg/ml, P 〈 0.01 ; ELISA using antibodies against ox-LDL: ( 13.0 ± 13.8 ) μg/ml vs (7. 3 ±9.7) μg/ml, P 〈 0. 01, respectively]. Results obtained with the two ELISA methods were closely correlated (r = 0. 78, P 〈 0. 01 ). Conclusions Autoantibodies against ox-Lp (a) can recognize both ape (a) and apoB epitopes of ox-Lp (a). A new ELISA for ox-Lp (a) by using human antibodies has been developed. Increased serum ox-Lp(a) has been observed in the CHD patients.

同期刊论文项目
同项目期刊论文
期刊信息
  • 《临床检验杂志》
  • 北大核心期刊(2011版)
  • 主管单位:江苏省卫生和计划生育委员会
  • 主办单位:江苏省医学会
  • 主编:许文荣
  • 地址:南京市中央路42号
  • 邮编:210008
  • 邮箱:editor@lcjyzz.com
  • 电话:025-83620683
  • 国际标准刊号:ISSN:1001-764X
  • 国内统一刊号:ISSN:32-1204/R
  • 邮发代号:28-104
  • 获奖情况:
  • 国家科技部中国科技论文统计源期刊,中国科学引文数据库医学类核心期刊,中国期刊方阵“双效”期刊
  • 国内外数据库收录:
  • 美国化学文摘(网络版),日本日本科学技术振兴机构数据库,中国中国科技核心期刊,中国北大核心期刊(2004版),中国北大核心期刊(2008版),中国北大核心期刊(2011版),中国北大核心期刊(2000版)
  • 被引量:21982